GNE-9605

  • CAT Number: I001933
  • CAS Number: 1536200-31-3
  • Molecular Formula: C17H20ClF4N7O
  • Molecular Weight: 449.83
  • Purity: ≥95%
Inquiry Now

GNE-9605(Cat No.:I001933) is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with Ki and IC50 of 2 nM and 19 nM, respectively. GNE-9605 is highly potent against LRRK2 in biochemical (Ki = 2.0 nM) and cellular (IC50 = 19 nM) assays. In the in vitro human MDR1 permeability data, GNE-9605 showed good brain penetration in higher species.

Catalog Number I001933
CAS Number 1536200-31-3
Molecular Formula

C17H20ClF4N7O

Purity 95%
Target LRRK2
Solubility DMSO: ≥ 60 mg/mL
Storage Store at -20°C
IUPAC Name 2-N-[5-chloro-1-[(3S,4S)-3-fluoro-1-(oxetan-3-yl)piperidin-4-yl]pyrazol-4-yl]-4-N-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine
InChI InChI=1S/C17H20ClF4N7O/c1-23-15-10(17(20,21)22)4-24-16(27-15)26-12-5-25-29(14(12)18)13-2-3-28(6-11(13)19)9-7-30-8-9/h4-5,9,11,13H,2-3,6-8H2,1H3,(H2,23,24,26,27)/t11-,13-/m0/s1
InChIKey PUXPEQJKNAWNQA-AAEUAGOBSA-N
SMILES CNC1=NC(=NC=C1C(F)(F)F)NC2=C(N(N=C2)C3CCN(CC3F)C4COC4)Cl
Reference

<p style=/line-height:25px/>
<br>[1]. Estrada AA, et al. Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem. 2014 Feb 13;57(3):921-36.
</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!